November 4, 2026

News, minutes after it breaks

Latest

Home  / Business

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

Image: CNBC

A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.

CNBC reported this story. Read the full report on cnbc.com →

This is a short summary. CNBC wrote and published the full report.

Continue on cnbc.com →

More in Business

Leave a Reply

Your email address will not be published. Required fields are marked *